Back to Search
Start Over
Low-Dose Cisplatin-Based Radiation Therapy for Refractory Recurrent Respiratory Papillomatosis.
- Source :
-
The Laryngoscope [Laryngoscope] 2024 May; Vol. 134 (5), pp. 2335-2337. Date of Electronic Publication: 2023 Oct 09. - Publication Year :
- 2024
-
Abstract
- Recurrent respiratory papilloma (RRP) often presents multiple lesions in the respiratory tract and sometimes becomes fatal because of severe airway obstruction. We report the case of a 69-year-old woman who had juvenile-onset RRP in the trachea that was refractory to surgical treatment, and complete remission was achieved by low-dose cisplatin combined with de-escalated radiotherapy without any side effects. This case report is the first to illustrate the data on low-dose cisplatin for refractory benign RRP, and our experience reinforces the opinion that low-dose cisplatin combined with de-escalated radiotherapy can be an effective and safe treatment alternative for uncontrollable and lethal RRP. Laryngoscope, 134:2335-2337, 2024.<br /> (© 2023 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.)
Details
- Language :
- English
- ISSN :
- 1531-4995
- Volume :
- 134
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Laryngoscope
- Publication Type :
- Report
- Accession number :
- 37812337
- Full Text :
- https://doi.org/10.1002/lary.31096